Clinical trial
A Multicenter Prospective Open-label Single Arm Trial to Safely Discontinue Antiviral Treatment in Patients With HBeAg-Negative Chronic Hepatitis B and Low HBsAg Concentrations (ADAPT)
NCT04782375 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Prospective Open-label Single Arm Trial to Safely Discontinue Antiviral Treatment in Patients With HBeAg-Negative Chronic Hepatitis B and Low HBsAg Concentrations (ADAPT)
- Lead sponsor
- Asan Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 1, 2021
- Completion date
- June 30, 2026
- Enrollment
- 140 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.